Bahrun Bahrun
Research Subjects
Bahrun Bahrun has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Herlina Rasyid
Department of Chemistry, Faculty of Mathematics and Natural Sciences, Hasanuddin University, Jl. Perintis Kemerdekaan km 10, Makassar 90245, Indonesia
3 shared publications - Hakiki Melanie
Research Center for Molecular Chemistry, Nanotechnology and Materials Research Organization, National Research and Innovation Agency (BRIN), South Tangerang 15314, Indonesia
2 shared publications - Nina Artanti
Research Center for Chemistry, National Research and Innovation Agency (BRIN), Tangerang Selatan 15314, Banten, Indonesia
2 shared publications - Yulia Anita
Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan
2 shared publications - Ambo Tuwo
Department of Marine Science, Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Indonesia
1 shared publication - Anisa Sepyana
Department of Chemistry, Faculty of Mathematics and Natural Sciences, Hasanuddin University, Jl. Perintis Kemerdekaan km 10, Makassar 90245, Indonesia
1 shared publication
Latest Publications
- 19 November 2025
- Published by Elsevier in Biocatalysis and Agricultural Biotechnology
- Vol. 70
The effect of conventional and ultrasound-assisted extraction methods on phytochemical composition, antioxidant, and α-glucosidase inhibitory activities of Indonesian brown seaweeds (Sargassum duplicatum, Turbinaria ornata and Padina australis)
- 19 November 2025
- Published by Elsevier in Biocatalysis and Agricultural Biotechnology
- Vol. 70
The effect of conventional and ultrasound-assisted extraction methods on phytochemical composition, antioxidant, and α-glucosidase inhibitory activities of Indonesian brown seaweeds (Sargassum duplicatum, Turbinaria ornata and Padina australis)
- 13 November 2025
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 25 (3) , 2367-2388
A review of chemical diversity of Kappaphycus alvarezii: biological properties, health benefits, and food applications
- 13 November 2025
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 25 (3) , 2367-2388
A review of chemical diversity of Kappaphycus alvarezii: biological properties, health benefits, and food applications
- Open Access
- 1 October 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (5) , 1384-1395
Toxicity and α-Amylase Inhibitory Potential of Tagetes erecta Leaf Extract: In Vitro and In Silico Approaches
Tagetes erecta is one of traditional herbs with a variety of pharmacological actions. This study attempted to assess the toxicity and antidiabetic activity of T. erecta leaf extract. The extraction was carried out by maceration, then continued with phytochemical analysis. Toxicity of the extract was conducted using the brine shrimp lethality test. The antidiabetic activity was evaluated by α-amylase inhibitory using the 3,5-dinitrosalicylic acid method. The phytochemical of the most active extract was identified using GC-MS and subjected to bind the α-amylase (PDB ID: 2QV4) employing molecular docking. The LC50 values of n-hexane, EtOAc, and MeOH extracts were 33.41, 14.00, and 35.03 ppm, respectively, indicating high toxicity. The antidiabetic activity showed that EtOAc extract has the lowest IC50 value (1053.95 mg/L). Molecular docking analysis revealed the compounds 1–5 has range of binding energy at −4.07 to −4.83 kcal/mol. Acarbose as a positive control showed the lower binding energy at −5.03 kcal/mol, indicated more effective α-amylase inhibitory. This study revealed that T. erecta leaf extract has significant cytotoxic potential, which may warrant further exploration for anticancer applications. However, the relatively weak α-amylase inhibitory and lower binding affinity compared to acarbose imply limited utility as an antidiabetic agent.
- 1 October 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (5) , 1384-1395
Open AccessToxicity and α-Amylase Inhibitory Potential of Tagetes erecta Leaf Extract: In Vitro and In Silico Approaches
Tagetes erecta is one of traditional herbs with a variety of pharmacological actions. This study attempted to assess the toxicity and antidiabetic activity of T. erecta leaf extract. The extraction was carried out by maceration, then continued with phytochemical analysis. Toxicity of the extract was conducted using the brine shrimp lethality test. The antidiabetic activity was evaluated by α-amylase inhibitory using the 3,5-dinitrosalicylic acid method. The phytochemical of the most active extract was identified using GC-MS and subjected to bind the α-amylase (PDB ID: 2QV4) employing molecular docking. The LC50 values of n-hexane, EtOAc, and MeOH extracts were 33.41, 14.00, and 35.03 ppm, respectively, indicating high toxicity. The antidiabetic activity showed that EtOAc extract has the lowest IC50 value (1053.95 mg/L). Molecular docking analysis revealed the compounds 1–5 has range of binding energy at −4.07 to −4.83 kcal/mol. Acarbose as a positive control showed the lower binding energy at −5.03 kcal/mol, indicated more effective α-amylase inhibitory. This study revealed that T. erecta leaf extract has significant cytotoxic potential, which may warrant further exploration for anticancer applications. However, the relatively weak α-amylase inhibitory and lower binding affinity compared to acarbose imply limited utility as an antidiabetic agent.
- Open Access
- 31 July 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (4) , 1280-1290
In Silico Study of Alkaloid Compounds from Sida rhombifolia (Sidaguri) as Antimalarial Agents Targeting Plasmodium falciparum Dihydrofolate Reductase
Malaria, caused by the Plasmodium parasite, represents a significant global health challenge, with approximately 229 million cases reported in 2020. Current treatments include artemisinin-based combination therapy; however, drug resistance poses serious issues. Natural products, including alkaloids from Sida rhombifolia, particularly cryptolepine, effectively inhibit Plasmodium falciparum through DNA intercalation. Research indicates that mutations in the PfDHFR enzyme of P. falciparum contribute to drug resistance, highlighting the urgent need for new inhibitors. A literature review combined with SwissADME, toxicology predictions, and molecular docking methods identified 11-cryptolepine carboxylic acid (B1) and N-trans-feruloyl tyramine (B11) as potential new inhibitors. The compounds exhibited binding energies of −7.22 and −8.41 kcal/mol, which are close to the native ligand (−7.31 kcal/mol). Additionally, they demonstrate favorable drug-likeness properties, indicating their potential as viable candidates for drug development. The molecular dynamics simulation for 100 ns was conducted to observe molecular interactions in a specific system dynamically. It was found that ligand B1 has better stability compared to ligand B11. This compound demonstrates significant potential for advancing malaria treatment strategies. Further research and clinical evaluation are warranted to fully realize their potential and translate these findings into effective clinical interventions for combating malaria globally.
- 31 July 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (4) , 1280-1290
Open AccessIn Silico Study of Alkaloid Compounds from Sida rhombifolia (Sidaguri) as Antimalarial Agents Targeting Plasmodium falciparum Dihydrofolate Reductase
Malaria, caused by the Plasmodium parasite, represents a significant global health challenge, with approximately 229 million cases reported in 2020. Current treatments include artemisinin-based combination therapy; however, drug resistance poses serious issues. Natural products, including alkaloids from Sida rhombifolia, particularly cryptolepine, effectively inhibit Plasmodium falciparum through DNA intercalation. Research indicates that mutations in the PfDHFR enzyme of P. falciparum contribute to drug resistance, highlighting the urgent need for new inhibitors. A literature review combined with SwissADME, toxicology predictions, and molecular docking methods identified 11-cryptolepine carboxylic acid (B1) and N-trans-feruloyl tyramine (B11) as potential new inhibitors. The compounds exhibited binding energies of −7.22 and −8.41 kcal/mol, which are close to the native ligand (−7.31 kcal/mol). Additionally, they demonstrate favorable drug-likeness properties, indicating their potential as viable candidates for drug development. The molecular dynamics simulation for 100 ns was conducted to observe molecular interactions in a specific system dynamically. It was found that ligand B1 has better stability compared to ligand B11. This compound demonstrates significant potential for advancing malaria treatment strategies. Further research and clinical evaluation are warranted to fully realize their potential and translate these findings into effective clinical interventions for combating malaria globally.
- Open Access
- 28 March 2024
- Published by Elsevier in Kuwait Journal of Science
- Vol. 51 (3)
Chemotherapeutic prospects of organic extracts of Bornetella nitida from Selayar Island
- 28 March 2024
- Published by Elsevier in Kuwait Journal of Science
- Vol. 51 (3)
Open AccessChemotherapeutic prospects of organic extracts of Bornetella nitida from Selayar Island